Medimaging Integrated Solution Inc. (TPE:6796)
39.35
-0.85 (-2.11%)
Nov 20, 2026, 1:30 PM CST
TPE:6796 Revenue
Medimaging Integrated Solution had revenue of 215.19M TWD in the quarter ending September 30, 2026, with 40.84% growth. This brings the company's total for the last twelve months to 744.42M, up 13.44% year-over-year. In the year 2025, Medimaging Integrated Solution had annual revenue of 661.39M with 22.72% growth. That makes Medimaging Integrated Solution the 33,165th largest company in the world by revenue and 1,705th in Taiwan.
Revenue (ttm)
744.42M
Revenue Growth
+13.44%
P/S Ratio
2.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.58B
Revenue by Geography
- United States 499.17M 75.5%
- Taiwan 75.58M 11.4%
- Other 62.76M 9.5%
- Mainland China 23.87M 3.6%
Fiscal year ended Dec 31, 2025 See the full TPE:6796 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 661.39M | 122.47M | 22.72% |
| Dec 31, 2024 | 538.92M | 1.77M | 0.33% |
| Dec 31, 2023 | 537.15M | 35.06M | 6.98% |
| Dec 31, 2022 | 502.09M | 16.22M | 3.34% |
| Dec 31, 2021 | 485.87M | 83.40M | 20.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wellell | 2.56B |
| OK Biotech | 1.72B |
| Dynamic Medical Technologies | 1.42B |
| AViTA | 1.05B |
| A Plus Biotechnology | 919.38M |
| Bioptik Technology Incorporation | 891.73M |
| Applied BioCode | 728.39M |
| Bonraybio | 346.06M |